Working Paper |
File Downloads |
Abstract Views |
Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
(Un)conventional combinations: At the origins of breakthrough inventions |
0 |
0 |
0 |
10 |
0 |
0 |
3 |
28 |
A Comparison of U.S. And European University-Industry Relations in the Life Sciences |
0 |
0 |
0 |
0 |
0 |
7 |
19 |
374 |
A Comparison of U.S. and European University-Industry Relations in the Life Sciences |
0 |
0 |
0 |
62 |
0 |
6 |
23 |
321 |
A Few Special Cases: Scientific Creativity and Network Dynamics in the Field of Rare Diseases |
0 |
0 |
0 |
24 |
2 |
2 |
12 |
141 |
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence |
0 |
0 |
0 |
9 |
0 |
1 |
6 |
74 |
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence |
0 |
0 |
0 |
4 |
0 |
1 |
4 |
39 |
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment |
0 |
0 |
0 |
3 |
0 |
1 |
4 |
64 |
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment |
0 |
0 |
0 |
5 |
0 |
1 |
4 |
79 |
A Trick of the (Pareto) Tail |
0 |
0 |
0 |
53 |
0 |
1 |
13 |
178 |
An extreme value analysis of the last century crises across industries in the U.S. economy |
0 |
0 |
1 |
13 |
1 |
1 |
3 |
45 |
Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks |
0 |
0 |
1 |
22 |
0 |
0 |
2 |
135 |
Biomedical Innovation Clusters |
0 |
0 |
3 |
8 |
0 |
0 |
6 |
29 |
Brain-Circulation Network: The Global Mobility of the Life Scientists |
0 |
3 |
12 |
73 |
1 |
14 |
45 |
147 |
Cluster analysis of weighted bipartite networks: a new copula-based approach |
0 |
0 |
0 |
53 |
0 |
0 |
3 |
47 |
Co-evolution of Organizational Forms and Technology |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
245 |
Co-experience Network Dynamics: Lessons from the Dance Floor |
0 |
0 |
0 |
25 |
0 |
1 |
3 |
60 |
Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry |
0 |
0 |
0 |
233 |
0 |
0 |
3 |
453 |
Crescita proporzionale e politiche pubbliche: proposte per una sintesi evolutiva |
0 |
0 |
0 |
18 |
0 |
0 |
1 |
110 |
Crescita, occupazione e sostenibilità - Il ruolo delle infrastrutture digitali |
0 |
0 |
1 |
12 |
1 |
1 |
5 |
72 |
Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure |
0 |
0 |
5 |
142 |
1 |
3 |
15 |
488 |
From La Bohème to La Wally: How Organizational Status Affects the (Un)conventionality of Opera Repertoires |
0 |
0 |
1 |
5 |
0 |
1 |
14 |
44 |
Global Networks of Trade and Bits |
0 |
0 |
1 |
54 |
0 |
3 |
9 |
119 |
Global Value Trees |
0 |
0 |
2 |
9 |
0 |
0 |
8 |
25 |
Global Virtual Water Trade: Integrating Structural Decomposition Analysis with Network Theory |
0 |
0 |
0 |
47 |
1 |
1 |
9 |
56 |
Global Virtual Water Trade: integrating Structural Decomposition Analysis with Network Theory |
0 |
0 |
0 |
36 |
0 |
1 |
5 |
61 |
Global value trees |
0 |
0 |
0 |
63 |
0 |
2 |
4 |
38 |
Homophily and Triadic Closure in Evolving Social Networks |
0 |
0 |
2 |
59 |
1 |
1 |
8 |
80 |
I Farmaci Oncologici in Italia: innovazione e sostenibilità economica |
0 |
1 |
3 |
48 |
1 |
4 |
15 |
200 |
Identifying Geographic Clusters: A Network Analytic Approach |
0 |
0 |
0 |
56 |
1 |
1 |
2 |
61 |
Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato |
0 |
0 |
0 |
14 |
0 |
1 |
4 |
107 |
Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico |
0 |
0 |
2 |
17 |
1 |
1 |
7 |
102 |
Innovation and Corporate Dynamics: A Theoretical Framework |
0 |
0 |
0 |
66 |
0 |
1 |
5 |
122 |
Innovation and Corporate Dynamics: A Theoretical Framework |
0 |
0 |
2 |
149 |
0 |
0 |
6 |
247 |
Innovation and Corporate Growth in the Evolution of the Drug Industry |
0 |
0 |
3 |
423 |
0 |
1 |
22 |
923 |
Innovation, trade and the size of exporting firms |
0 |
0 |
0 |
41 |
0 |
2 |
5 |
59 |
Is There a Productivity Crisis in Pharmaceutical R&D? |
1 |
1 |
1 |
6 |
2 |
3 |
6 |
25 |
La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale |
1 |
1 |
2 |
13 |
1 |
5 |
15 |
98 |
Market Structure and Drug Innovation |
0 |
0 |
1 |
30 |
0 |
1 |
6 |
131 |
Medical Devices Competitiveness and Impact on Public Health Expenditure |
1 |
2 |
7 |
176 |
3 |
12 |
64 |
701 |
Medical Devices: Competitiveness and Impact on Public Health Expenditure |
0 |
0 |
1 |
26 |
1 |
4 |
22 |
144 |
Missing Links in Multiple Trade Networks |
0 |
0 |
0 |
23 |
1 |
1 |
6 |
52 |
Monthly Report No. 03/2020 |
0 |
1 |
2 |
2 |
2 |
5 |
8 |
8 |
Networks Dynamics in the Pharmaceutical Industry |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
252 |
Networks of innovators within and across borders. Evidence from patent data |
0 |
0 |
4 |
111 |
1 |
1 |
9 |
224 |
Nuove politiche per l'innovazione nel settore delle scienze della vita |
0 |
0 |
0 |
6 |
1 |
1 |
6 |
82 |
On Firm Growth in Networks |
0 |
0 |
0 |
19 |
0 |
0 |
2 |
108 |
On Size and Growth of Business Firms |
0 |
0 |
0 |
32 |
0 |
2 |
9 |
330 |
Pareto versus lognormal: a maximum entropy test |
0 |
0 |
3 |
94 |
0 |
1 |
11 |
184 |
Patent Disclosure and R&D Competition in Pharmaceuticals |
0 |
0 |
0 |
117 |
2 |
3 |
6 |
306 |
Patent Disclosure and R&D Competition in Pharmaceuticals |
0 |
0 |
1 |
107 |
2 |
2 |
7 |
182 |
Patent Value and R&D Competition |
0 |
0 |
0 |
1 |
0 |
1 |
6 |
30 |
Preferential attachment and growth dynamics in complex systems |
0 |
0 |
0 |
17 |
0 |
0 |
3 |
101 |
Processes of corporate growth in the evolution of an innovation-driven industry. The case of pharmaceuticals |
0 |
0 |
0 |
247 |
0 |
0 |
4 |
514 |
Quali Regole per la Spesa Farmaceutica? - Criticità, Impatti, Proposte |
0 |
1 |
4 |
5 |
3 |
7 |
21 |
28 |
Radical Innovation and Network Evolution |
0 |
0 |
0 |
141 |
0 |
0 |
4 |
338 |
Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica |
0 |
0 |
0 |
12 |
1 |
2 |
6 |
87 |
Statistical Properties of Business Firms Structure and Growth |
0 |
0 |
0 |
17 |
1 |
1 |
1 |
79 |
Stochastic Trade Networks |
0 |
0 |
1 |
30 |
0 |
2 |
9 |
84 |
Stochastic Trade Networks |
0 |
0 |
2 |
89 |
0 |
0 |
5 |
188 |
Structure of Business Firm Networks and Scale-Free Models |
0 |
0 |
0 |
11 |
0 |
2 |
5 |
92 |
Structure of Business Firm Networks and Scale-Free Models |
0 |
1 |
1 |
53 |
0 |
1 |
2 |
233 |
Systemic importance of financial institutions: from a global to a local perspective? A network theory approach |
1 |
1 |
2 |
92 |
1 |
1 |
11 |
122 |
Systemic importance of financial institutions: regulations, research, open issues, proposals |
0 |
1 |
2 |
50 |
1 |
8 |
14 |
198 |
Systemic risk and banking regulation: some facts on the new regulatory framework |
0 |
1 |
3 |
137 |
2 |
3 |
10 |
216 |
Talents from Abroad. Foreign Managers and Productivity in the United Kingdom |
1 |
2 |
34 |
52 |
4 |
10 |
43 |
47 |
Technological Regimes and the Growth of Networks An Empirical Analysis |
0 |
0 |
0 |
129 |
0 |
0 |
3 |
349 |
The Global Health Networks: A Comparative Analysis of Tuberculosis, Malaria and Pneumonia Using Social Media Data |
1 |
1 |
2 |
72 |
2 |
4 |
15 |
60 |
The Growth of Business Firms: Theoretical Framework and Empirical Evidence |
0 |
0 |
1 |
17 |
1 |
3 |
7 |
108 |
The Growth of Business Firms: Theoretical Framework and Empirical Evidence |
0 |
0 |
5 |
163 |
9 |
31 |
110 |
1,576 |
The Indirect Effects of FDI on Trade: A Network Perspective |
1 |
1 |
2 |
42 |
1 |
3 |
24 |
77 |
The Indirect Effects of FDI on Trade: A Network Perspective |
0 |
0 |
1 |
38 |
0 |
0 |
10 |
35 |
The Nature and the Extent of the Market for Technology in Biopharmaceuticals |
0 |
0 |
0 |
44 |
0 |
1 |
9 |
173 |
The Network of U.S. Mutual Fund Investments: Diversification, Similarity and Fragility throughout the Global Financial Crisis |
0 |
0 |
3 |
19 |
0 |
2 |
11 |
26 |
The Relation Between Global Migration and Trade Networks |
0 |
0 |
4 |
45 |
0 |
0 |
10 |
106 |
The Relation Between Global Migration and Trade Networks |
0 |
0 |
1 |
19 |
0 |
2 |
10 |
60 |
The Similarity of Global Value Chains: A Network-Based Measure |
0 |
0 |
1 |
55 |
3 |
4 |
17 |
85 |
The Similarity of Global Value Chains: A Network-Based Measure |
0 |
0 |
1 |
41 |
0 |
1 |
11 |
73 |
The Size Variance Relationship of Business Firm Growth Rates |
0 |
0 |
0 |
37 |
0 |
0 |
1 |
95 |
The Size Variance Relationship of Business Firm Growth Rates |
0 |
0 |
0 |
27 |
0 |
0 |
3 |
77 |
The Size Variance Relationship of Business Firm Growth Rates |
0 |
0 |
1 |
32 |
1 |
1 |
8 |
87 |
The Structure and Growth of International Trade |
0 |
0 |
1 |
105 |
0 |
1 |
8 |
215 |
The Structure and Growth of International Trade |
0 |
0 |
0 |
67 |
0 |
3 |
9 |
226 |
The Structure and Growth of International Trade |
2 |
2 |
2 |
24 |
2 |
3 |
7 |
99 |
The Structure and Growth of Weighted Networks |
0 |
0 |
0 |
63 |
0 |
0 |
5 |
155 |
The Structure and Growth of World Trade, and the Role of Europe in the Global Economy |
1 |
1 |
2 |
37 |
1 |
1 |
6 |
91 |
The Sustainability of European Health Care Systems: Beyond Income and Ageing |
0 |
1 |
1 |
2 |
1 |
2 |
6 |
36 |
The Sustainability of European Health Care Systems: Beyond Income and Ageing |
0 |
1 |
1 |
57 |
0 |
2 |
4 |
193 |
The Value of Failures in Pharmaceutical R&D |
0 |
0 |
0 |
30 |
1 |
2 |
10 |
128 |
The evolution of networks of innovators within and across borders: Evidence from patent data |
1 |
1 |
4 |
143 |
1 |
1 |
17 |
194 |
The migration network effect on international trade |
0 |
0 |
5 |
115 |
0 |
0 |
11 |
171 |
The productivity crisis in pharmaceutical R&D |
1 |
1 |
6 |
167 |
2 |
5 |
16 |
465 |
The rise of China in the international trade network: a community core detection approach |
0 |
0 |
0 |
36 |
0 |
0 |
4 |
68 |
Virtual Water Trade and Bilateral Conflicts |
0 |
1 |
2 |
29 |
1 |
4 |
5 |
52 |
Where Gibrat meets Zipf: Scale and Scope of French Firms |
0 |
1 |
1 |
49 |
0 |
4 |
9 |
108 |
World Input-Output Network |
1 |
1 |
3 |
137 |
1 |
4 |
14 |
108 |
World Input-Output Network |
1 |
1 |
1 |
51 |
1 |
1 |
6 |
51 |
Total Working Papers |
14 |
29 |
161 |
5,465 |
68 |
224 |
1,006 |
15,904 |